The Claim

Announced Operation Stork Speed to expand options for safe, reliable, and nutritious infant formula for American families.

The Claim, Unpacked

What is literally being asserted?

That the administration announced an initiative called Operation Stork Speed, and that this initiative aims to expand options for infant formula that is safe, reliable, and nutritious. The claim uses the word “announced” — it does not claim implementation or results.

What is being implied but not asserted?

That the administration is taking decisive, large-scale action to improve infant formula for American families. The name “Operation Stork Speed” deliberately echoes “Operation Warp Speed,” the first Trump administration’s COVID-19 vaccine acceleration program, implying a similar level of urgency, resources, and ambition. The framing suggests the administration is proactively protecting infants.

What is conspicuously absent?

That the announcement was made one day after Consumer Reports shared test results with the FDA showing that roughly half of 41 powdered infant formulas tested contained potentially harmful levels of at least one contaminant — suggesting the announcement was reactive rather than proactive. That the same administration is simultaneously cutting the FDA’s budget and workforce, undermining the agency’s capacity to implement the initiative. That the FDA’s long-term infant formula strategy, published January 10, 2025 under the Biden administration, had already laid groundwork for many of the same goals. That nearly a year after announcement, no concrete regulatory changes have been finalized. And that the ByHeart infant botulism outbreak of November 2025 — which sickened 51 infants across 19 states — occurred on Operation Stork Speed’s watch.

Evidence Assessment

Established Facts

Operation Stork Speed was announced on March 18, 2025, by HHS Secretary Robert F. Kennedy Jr. and the FDA. ¹ The initiative encompasses six stated actions: (1) initiating the first comprehensive infant formula nutrient review since 1998, (2) expanding testing for heavy metals and other contaminants, (3) extending the personal importation policy for formula, (4) improving transparency in labeling, (5) establishing regular stakeholder communication, and (6) partnering with NIH on formula feeding research.

The announcement came one day after Consumer Reports shared its test results with the FDA showing contamination in infant formulas. ² Consumer Reports tested 41 powdered formulas and found that roughly half contained potentially harmful levels of at least one contaminant, including inorganic arsenic in seven formulas and concerning levels of lead in 18 formulas. PFAS was detected in almost all formulas tested.

The FDA’s last comprehensive review of infant formula nutrient requirements was in 1998. ³ The most recent individual nutrient update was in 2015, when selenium was added to the required list at 21 CFR 107.100. The existing regulations specify 30 required nutrients with minimum levels for each and maximum levels for only 10. Most underlying formula safety standards date to 1985 with only minor amendments since.

On May 13, 2025, the FDA issued a Request for Information to begin the nutrient review process. ⁴ The RFI sought public input on six specific questions, including whether existing nutrients warrant revision, whether additional nutrients like DHA and ARA should be required, and whether any nutrients should be removed. The comment period closed September 11, 2025. An expert panel was convened in June 2025.

The Biden-era FDA published a “Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market” on January 10, 2025 — just 10 days before the administration transition. ⁵ This strategy built on the 2023 Immediate National Strategy developed in response to the 2022 Abbott recall and shortage. Operation Stork Speed’s announcement made no reference to this existing strategy, raising coordination questions noted by legal analysts.

The ByHeart infant botulism outbreak in November 2025 sickened 51 infants across 19 states, occurring eight months after Operation Stork Speed’s launch. ⁶ ByHeart’s voluntary recall began November 8, 2025, expanding on November 11 to all products. FDA testing found Clostridium botulinum toxin (Type A) in two samples. FDA subsequently sent warning letters to major retailers including Target, Walmart, and Kroger for failing to remove recalled products from shelves.

Strong Inferences

The U.S. infant formula market is extremely concentrated, with four manufacturers controlling 99% of the market. ⁷ As of 2021, Abbott held 40%, Mead Johnson/Reckitt 31%, Nestle/Gerber 17%, and Perrigo 11%. The WIC program — the government’s single largest infant formula purchaser — has contracted with as few as two manufacturers nationally. This concentration was a major factor in the 2022 shortage when Abbott’s Sturgis facility shut down.

The administration’s simultaneous FDA budget cuts and workforce reductions significantly undermine the capacity to implement Operation Stork Speed. ⁸ The FDA lost approximately 3,859 employees in 2025 and 473 more by early 2026. Deputy Commissioner Jim Jones, who oversaw the Human Foods Program, resigned following DOGE-driven layoffs. The HHS FY2026 budget proposed a $271 million decrease for FDA overall, though it earmarked $14.7 million specifically for infant formula oversight modernization. A spending freeze in January 2025 left Human Foods Program staff unable to perform routine tasks like purchasing food samples for testing. Brian Ronholm of Consumer Reports warned: “There is a risk of this becoming a false promise, especially if the current trend of additional budget cuts, additional staffing cuts across government agencies continues.”

Operation Stork Speed’s name is designed to evoke Operation Warp Speed, but the comparison is misleading. ⁹ Operation Warp Speed committed approximately $18 billion in federal funding and produced regulatory-approved vaccines within a year. Operation Stork Speed has committed $14.7 million in its budget request — less than one-tenth of one percent of Warp Speed’s funding. Nearly a year after announcement, it has produced one Request for Information, one expert panel, and one dairy ingredient sampling assignment. No regulatory changes have been finalized.

The U.S. lacks established maximum allowable levels for any environmental contaminants in infant formula. ¹⁰ The June 2025 expert panel explicitly highlighted this regulatory gap, noting that unlike the EU and Australia, the United States has set no maximum limits for lead, arsenic, cadmium, mercury, PFAS, microplastics, or other environmental contaminants in formula. Addressing this gap would require either rulemaking or Congressional action — processes that typically take years.

Informed Speculation

The initiative’s emphasis on reducing “regulatory barriers” for new formula entrants may serve as a vehicle for deregulation that could compromise safety standards, particularly given HHS Secretary Kennedy’s characterization of existing regulations as “archaic science.” Commissioner Makary’s acknowledgment of consumer interest in formulas “free of certain ingredients such as seed oils” suggests ideological considerations may influence what should be a science-driven nutrient review. Industry experts and pediatricians note that seed oils provide linoleic acid, an essential fatty acid also found in breast milk, and removing them without validated alternatives could disrupt infant nutrition.

What the Evidence Shows

The announcement of Operation Stork Speed is real and accurately described by this claim. The initiative identifies genuine problems: infant formula nutrient standards that have not been comprehensively reviewed in over 25 years, no federal limits on environmental contaminants in formula, insufficient testing, and a dangerously concentrated market susceptible to supply disruptions. These are substantive issues that warrant federal attention.

However, the gap between announcement and implementation is significant. Nearly a year after its March 2025 launch, Operation Stork Speed’s tangible outputs consist of one Request for Information, one expert panel, and the initiation of a dairy ingredient sampling program in February 2026. No new contaminant limits have been established. No regulatory changes have been finalized. The FDA itself acknowledges it is “still seeking additional authority from Congress” to fully implement the initiative’s goals. The comprehensive report examining contaminants and nutrient requirements is not expected until spring 2026 — over a year after the announcement.

More problematic is the structural contradiction at the core of the initiative. The same administration that announced Operation Stork Speed also cut thousands of FDA positions, proposed a $271 million decrease to the FDA’s overall budget, and implemented a spending freeze that hampered the Human Foods Program’s basic operations. The $14.7 million earmarked for infant formula oversight modernization, while welcome, represents a narrow resource commitment within a broader context of diminished agency capacity. The ByHeart botulism outbreak — which sickened 51 infants eight months after Operation Stork Speed’s launch — demonstrated that the existing oversight apparatus was already strained.

The initiative also builds on work that preceded it. The Biden-era FDA published a Long-Term National Strategy for infant formula market resilience just 10 days before the administration change, and the 2022 enforcement discretion policy for formula imports was a Biden-era response to the Abbott shortage. Operation Stork Speed does not acknowledge this continuity.

The Bottom Line

The claim is technically accurate: the administration did announce Operation Stork Speed, and its stated goals include expanding options for safe, reliable, and nutritious infant formula. Credit where due — the initiative correctly identifies real deficiencies in U.S. infant formula oversight, including outdated nutrient standards and the absence of contaminant limits that exist in other developed nations. The expert panel and nutrient review, if followed through, could produce meaningful improvements.

But the claim presents an announcement as an achievement. A year into the initiative, no new regulations have been finalized, no contaminant limits have been established, and the FDA report is still pending. The administration is simultaneously undermining the agency’s capacity to execute this work through budget cuts and workforce reductions that have left the Human Foods Program significantly diminished. The evocative name — designed to echo the well-funded Operation Warp Speed — creates an impression of urgency and scale that the actual resource commitment does not support. This is an announcement being counted as a win before the work is done.

Footnotes

1. FDA, “HHS, FDA Announce Operation Stork Speed to Expand Options for Safe, Reliable, and Nutritious Infant Formula for American Families,” March 18, 2025. https://www.fda.gov/news-events/press-announcements/hhs-fda-announce-operation-stork-speed-expand-options-safe-reliable-and-nutritious-infant-formula ↩

2. Consumer Reports, “Consumer Reports Tests Find Some Infant Formulas Contain Potentially Harmful Levels of Arsenic and Lead; Most Samples Did Not Raise Concerns,” March 2025. https://www.consumerreports.org/media-room/press-releases/2025/03/consumer-reports-tests-find-some-infant-formulas-contain-potentially-harmful-levels-of-arsenic-and-lead-most-samples-did-not-raise-concerns/ ↩

3. 21 CFR Part 107, Infant Formula. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-107; FDA Law Blog, “It’s a Bird, It’s a Plane, It’s Operation Stork Speed,” March 2025. https://www.thefdalawblog.com/2025/03/its-a-bird-its-a-plane-its-operation-stork-speed/ ↩

4. FDA, “HHS, FDA Initiate Comprehensive Review of Nutrients in Infant Formula,” May 13, 2025. https://www.fda.gov/news-events/press-announcements/hhs-fda-initiate-comprehensive-review-nutrients-infant-formula ↩

5. FDA, “Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market,” January 10, 2025. https://www.fda.gov/food/infant-formula-guidance-documents-regulatory-information/long-term-national-strategy-increase-resiliency-us-infant-formula-market ↩

6. FDA, “Outbreak Investigation of Infant Botulism: Infant Formula (November 2025).” https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-infant-botulism-infant-formula-november-2025 ↩

7. FTC, “Market Factors Relevant to Infant Formula Supply Disruptions,” 2022. https://www.ftc.gov/system/files/ftc_gov/pdf/infant_formula_report_final.pdf ↩

8. Scientific American, “RFK Jr. Wants to Make Baby Formula Safer, but Trump Budget Cuts Imperil That Effort,” 2025. https://www.scientificamerican.com/article/rfk-jr-wants-to-make-baby-formula-safer-but-trump-budget-cuts-imperil-that/; Food Navigator, “FDA and USDA staff cuts under Trump raise food safety risks,” February 16, 2026. https://www.foodnavigator-usa.com/Article/2026/02/16/fda-and-usda-staff-cuts-under-trump-raise-food-safety-risks/ ↩

9. FDA Law Blog, “It’s a Bird, It’s a Plane, It’s an UPDATE on Operation Stork Speed,” May 2025. https://www.thefdalawblog.com/2025/05/its-a-bird-its-a-plane-its-an-update-on-operation-stork-speed/; Food Navigator, “FDA’s Stork Speed initiative draws both praise and skepticism from formula stakeholders,” September 11, 2025. https://www.foodnavigator-usa.com/Article/2025/09/11/fdas-stork-speed-initiative-draws-both-praise-and-skepticism-from-formula-stakeholders/ ↩

10. Food Safety Magazine, “Operation Stork Speed Expert Panel Highlights Infant Formula Safety Vulnerabilities,” 2026. https://www.food-safety.com/articles/11053-operation-stork-speed-expert-panel-highlights-infant-formula-safety-vulnerabilities ↩